MRP-L1 Inhibitors

Chemical inhibitors of Large ribosomal subunit protein uL1m (MRPL1) primarily function by targeting the mitochondrial protein synthesis process, in which MRPL1 plays a critical role. Chloramphenicol, Tetracycline, Erythromycin, Azithromycin, Linezolid, and Clindamycin inhibit MRPL1 by binding to the mitochondrial ribosome. This binding disrupts the normal function of the mitochondrial ribosome, consequently affecting MRPL1's role in mitochondrial protein synthesis. For example, Chloramphenicol inhibits MRPL1 by affecting peptide bond formation in the mitochondrial ribosome, while Tetracycline and Erythromycin interfere with aminoacyl-tRNA's access to the ribosome, a crucial step in protein synthesis where MRPL1 is involved. Similarly, Azithromycin and Linezolid disrupt MRPL1's function by hindering the peptidyl transferase activity of the mitochondrial ribosome, and Clindamycin affects peptide bond formation, all leading to inhibition of MRPL1's role in protein synthesis.

Other inhibitors, such as Doxycycline, Minocycline, Puromycin, Daptomycin, Fusidic Acid, and Rifampicin, exert their inhibitory effects on MRPL1 through different mechanisms within the mitochondrial protein synthesis process. Doxycycline and Minocycline inhibit MRPL1 by binding to the mitochondrial ribosome and preventing the incorporation of amino acids into growing peptide chains. Puromycin causes premature chain termination during protein synthesis, directly impacting MRPL1's function. Daptomycin's inhibition of MRPL1 is achieved by disrupting the mitochondrial membrane potential, which is essential for the protein synthesis process. Fusidic Acid targets the elongation factor G (EF-G) interaction in the mitochondrial ribosome, affecting the translocation step in protein synthesis. Lastly, Rifampicin inhibits MRPL1 by binding to the mitochondrial RNA polymerase, indirectly impacting the synthesis of proteins in which MRPL1 is involved. Each of these chemicals, through their specific actions, contributes to the inhibition of MRPL1, thereby impacting its role in mitochondrial protein synthesis.